COMPANY
Sidewinder Therapeutics
Raises and investors new
- InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗
Raises and deals from press releases
- Raise Series B · $137M · announced Apr 8, 2026 Company release ↗
Source quote
- Apr 8, 2026 · Company release ↗
“– Sidewinder Therapeutics, a biopharmaceutical company pioneering the development of next-generation bispecific ADCs (antibody-drug conjugates) for the treatment of cancer, today announced the closing of an oversubscribed $137 million Series B financing”
- Apr 8, 2026 · Company release ↗